---
title: "12 Health Care Stocks Moving In Wednesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291413881.md"
description: "In Wednesday's pre-market session, several healthcare stocks showed significant movement. Gainers included Can Fite Biopharma (up 52.0%), Atlantic International (up 17.39%), and Alzamend Neuro (up 14.58%). Conversely, losers featured INVO Fertility (down 14.7%), Creative Medical Tech (down 13.8%), and Redhill Biopharma (down 12.93%). The report highlights specific price changes and market capitalizations for these companies."
datetime: "2026-07-01T12:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291413881.md)
  - [en](https://longbridge.com/en/news/291413881.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291413881.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

### Gainers

-   **Can Fite Biopharma** (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $6.3 million.
-   **Atlantic International** (NASDAQ:ATLN) shares rose 17.39% to $1.08. The company's market cap stands at $74.7 million.
-   **Alzamend Neuro** (NASDAQ:ALZN) stock increased by 14.58% to $1.38. The market value of their outstanding shares is at $4.5 million.
-   **Matinas BioPharma Hldgs** (AMEX:MTNB) stock rose 11.11% to $0.68. The market value of their outstanding shares is at $3.9 million.
-   **Longeveron** (NASDAQ:LGVN) stock rose 9.51% to $0.77. The company's market cap stands at $22.2 million.
-   **Grace Therapeutics** (NASDAQ:GRCE) stock rose 9.25% to $2.48. The company's market cap stands at $36.9 million.

### Losers

-   **INVO Fertility** (NASDAQ:IVF) stock decreased by 14.7% to $1.62 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.3 million.
-   **Creative Medical Tech** (NASDAQ:CELZ) stock fell 13.8% to $1.25. The company's market cap stands at $5.3 million.
-   **Redhill Biopharma** (NASDAQ:RDHL) stock decreased by 12.93% to $0.74. The market value of their outstanding shares is at $4.3 million.
-   **CNS Pharmaceuticals** (NASDAQ:CNSP) stock declined by 9.21% to $4.34. The company's market cap stands at $6.9 million.
-   **Cuprina Holdings (Cayman)** (NASDAQ:CUPR) stock decreased by 8.96% to $6.0. The company's market cap stands at $17.6 million.
-   **rYojbaba** (NASDAQ:RYOJ) stock decreased by 8.57% to $2.35. The market value of their outstanding shares is at $28.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CANF.US](https://longbridge.com/en/quote/CANF.US.md)
- [RDHL.US](https://longbridge.com/en/quote/RDHL.US.md)
- [ATLN.US](https://longbridge.com/en/quote/ATLN.US.md)
- [IVF.US](https://longbridge.com/en/quote/IVF.US.md)
- [ALZN.US](https://longbridge.com/en/quote/ALZN.US.md)
- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [CIRC.US](https://longbridge.com/en/quote/CIRC.US.md)
- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)
- [LGVN.US](https://longbridge.com/en/quote/LGVN.US.md)
- [GRCE.US](https://longbridge.com/en/quote/GRCE.US.md)
- [CNSP.US](https://longbridge.com/en/quote/CNSP.US.md)
- [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md)
- [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md)
- [SQLLW.US](https://longbridge.com/en/quote/SQLLW.US.md)

## Related News & Research

- [Alzamend Neuro Phase 1/2A AL001 lithium fMRI data wins poster slot at SfN Neuroscience 2026](https://longbridge.com/en/news/296486724.md)
- [Alzamend Neuro Phase 1/2A AL001 lithium imaging data wins oral slot at ISMRM X-Nuclei MR workshop](https://longbridge.com/en/news/296225245.md)
- [Apptly Announces $1,000,000 Non-Brokered Private Placement | ESVNF Stock News](https://longbridge.com/en/news/296840063.md)
- [Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock](https://longbridge.com/en/news/296661262.md)
- [DraftKings (DKNG) Following Prediction Market Fears And New Debt Plans Looks Fully Valued](https://longbridge.com/en/news/296863548.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**